Document is current
Any future updates will be listed below
-
Authors
Kurch, Lars https://orcid.org/0000-0002-3396-4880
Dührsen, Ulrich
Hüttmann, Andreas
Georgi, Thomas W.
Sabri, Osama
Kluge, Regine
Hasenclever, Dirk
-
Funding
Funding for this research was provided by:
Universitätsklinikum Leipzig
- License Information
-
More Information
Article History
Received: 17 June 2021
Accepted: 17 August 2021
First Online: 14 September 2021
Declarations
:
: The PETAL trial (ClinicalTrials.gov NCT00554164; EudraCT 2006-001641-33) was a multicenter study for newly diagnosed aggressive non-Hodgkin lymphomas. The study was approved by the Federal Institute for Drugs and Medical Devices and the ethics committees of all participating sites. All patients gave written informed consent including their permission to use their data for post-hoc scientific analyses.
: UD received institutional research grants and honoraria from Amgen Germany and Roche Pharma. No other potential conflicts of interest relevant to this article exist.
